NMRD - Nemaura Medical Inc.
NASDAQ
->
Healthcare
->
Medical Devices
New York,
United States
Type: Equity
NMRD price evolution
NMRD
| (in millions $) | 31 Jan 2023 | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $10.11 | $14.75 | $17.75 | |
| Short term investments | ||||
| Net receivables | $0.38 | $0.22 | $0.1 | |
| Inventory | $1.49 | $1.91 | $1.63 | $1.49 |
| Total current assets | $20.09 | $13.95 | $17.7 | $20.09 |
| Long term investments | ||||
| Property, plant & equipment | $0.53 | $0.52 | $0.6 | $0.53 |
| Goodwill & intangible assets | $1.43 | $1.41 | $1.48 | |
| Total noncurrent assets | $1.95 | $2.02 | $2.01 | |
| Total investments | ||||
| Total assets | $22.1 | $15.9 | $19.72 | $22.1 |
| Current liabilities | ||||
| Accounts payable | $0.14 | $0.42 | $0.09 | $0.14 |
| Deferred revenue | $1.03 | $1.2 | $1.31 | |
| Short long term debt | $17.4 | $16.19 | $19.19 | |
| Total current liabilities | $20.58 | $20.47 | $17.95 | $20.58 |
| Long term debt | $3.49 | $4.7 | ||
| Total noncurrent liabilities | $4.45 | $5.72 | $1.05 | |
| Total debt | $20.89 | $20.89 | $19.19 | |
| Total liabilities | $21.64 | $24.91 | $23.67 | $21.64 |
| Shareholders' equity | ||||
| Retained earnings | -$37.73 | -$45.79 | -$41.71 | -$37.73 |
| Other shareholder equity | -$0.12 | -$1.54 | -$0.57 | -$0.12 |
| Total shareholder equity | -$9.01 | -$3.96 | $0.47 | |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $17.75 | $31.87 | $0.11 | $3.74 |
| Short term investments | ||||
| Net receivables | $0.1 | $0.38 | $0.09 | $0.1 |
| Inventory | $1.49 | $0.85 | $0.29 | $0.04 |
| Total current assets | $20.09 | $33.99 | $0.84 | $4.52 |
| Long term investments | ||||
| Property, plant & equipment | $0.53 | $0.2 | $0.16 | $0.06 |
| Goodwill & intangible assets | $1.48 | $1.06 | $0.21 | $0.19 |
| Total noncurrent assets | $2.01 | $1.26 | $0.38 | $0.25 |
| Total investments | ||||
| Total assets | $22.1 | $35.24 | $1.22 | $4.76 |
| Current liabilities | ||||
| Accounts payable | $0.14 | $0.25 | $0.29 | $0.16 |
| Deferred revenue | $1.31 | $1.38 | $1.24 | $1.3 |
| Short long term debt | $19.19 | $5.73 | ||
| Total current liabilities | $20.58 | $6.42 | $1.39 | $1.3 |
| Long term debt | $19.19 | $19.19 | ||
| Total noncurrent liabilities | $1.05 | $20.46 | $1.15 | $1.24 |
| Total debt | $19.19 | $24.92 | ||
| Total liabilities | $21.64 | $26.88 | $2.53 | $2.54 |
| Shareholders' equity | ||||
| Retained earnings | -$37.73 | -$23.84 | -$17.59 | -$13.43 |
| Other shareholder equity | -$0.12 | $0.14 | -$0.34 | -$0.34 |
| Total shareholder equity | $0.47 | $8.36 | -$1.31 | $2.23 |
| (in millions $) | 31 Jan 2023 | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.07 | $0.32 | ||
| Cost of revenue | $0.07 | $0.17 | ||
| Gross Profit | $0 | $0.15 | ||
| Operating activities | ||||
| Research & development | $0.26 | $0.33 | $0.57 | |
| Selling, general & administrative | $2.32 | $1.88 | $2.02 | |
| Total operating expenses | $2.58 | $2.21 | $2.59 | |
| Operating income | -$2.58 | -$2.21 | -$2.44 | |
| Income from continuing operations | ||||
| EBIT | -$2.58 | -$2.21 | -$2.44 | |
| Income tax expense | -$0.35 | |||
| Interest expense | $1.5 | $1.77 | $1.52 | |
| Net income | ||||
| Net income | -$4.08 | -$3.98 | -$3.62 | |
| Income (for common shares) | -$4.08 | -$3.98 | -$3.62 | |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.5 | |||
| Cost of revenue | $0.34 | |||
| Gross Profit | $0.16 | |||
| Operating activities | ||||
| Research & development | $1.56 | $1.55 | $2.01 | $2.3 |
| Selling, general & administrative | $6.17 | $3.03 | $2.77 | $2.18 |
| Total operating expenses | $7.73 | $4.59 | $4.78 | $4.48 |
| Operating income | -$7.57 | -$4.59 | -$4.78 | -$4.48 |
| Income from continuing operations | ||||
| EBIT | -$7.57 | -$4.59 | -$4.77 | -$4.45 |
| Income tax expense | -$0.35 | -$0.34 | -$0.61 | -$0.61 |
| Interest expense | $6.67 | $2.01 | ||
| Net income | ||||
| Net income | -$13.89 | -$6.26 | -$4.16 | -$4.45 |
| Income (for common shares) | -$13.89 | -$6.26 | -$4.16 | -$4.45 |
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | -$4.08 | -$3.98 | -$3.62 | -$3.43 |
| Operating activities | ||||
| Depreciation | $0.07 | $0.1 | $0.09 | $0.06 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.22 | |||
| Total cash flows from operations | -$2.16 | -$2.38 | -$2.15 | -$0.88 |
| Investing activities | ||||
| Capital expenditures | -$0.16 | -$0.22 | -$0.08 | -$0.19 |
| Investments | ||||
| Total cash flows from investing | -$0.16 | -$0.22 | -$0.08 | -$0.19 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.95 | $0.11 | ||
| Net borrowings | -$1.5 | -$0.07 | -$5.9 | -$2.7 |
| Total cash flows from financing | -$1.5 | -$0.07 | -$2.95 | -$2.59 |
| Effect of exchange rate | -$0.81 | -$0.32 | -$0.12 | -$0.07 |
| Change in cash and equivalents | -$4.96 | -$2.68 | -$5.17 | -$3.66 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$13.89 | -$6.26 | -$4.16 | -$4.45 |
| Operating activities | ||||
| Depreciation | $0.23 | $0.1 | $0.05 | $0.03 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.22 | $0.11 | $0.57 | $0.43 |
| Total cash flows from operations | -$6.5 | -$6 | -$3.45 | -$3.56 |
| Investing activities | ||||
| Capital expenditures | -$0.96 | -$0.84 | -$0.21 | -$0.08 |
| Investments | $4.48 | |||
| Total cash flows from investing | -$0.96 | -$0.84 | -$0.21 | $4.4 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $3.07 | $14.79 | $0.11 | $2.47 |
| Net borrowings | -$12.4 | $22.79 | -$0.04 | |
| Total cash flows from financing | -$6.37 | $37.99 | $0.1 | $2.05 |
| Effect of exchange rate | -$0.29 | $0.61 | -$0.07 | $0.03 |
| Change in cash and equivalents | -$13.83 | $31.15 | -$3.56 | $2.89 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 46.42 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.98 |
| Quick ratio | 0.90 |